Analyst firms · Oppenheimer · ORCL
Oppenheimer ORCL price target and rating history
Oracle Corporation (ORCL) · Technology
Oppenheimer rates Oracle Corporation (ORCL) Outperform with a $235 price target, as of its latest action on May 12, 2026. It has published 4 rating actions on ORCL since April 2024, including 1 upgrade and 0 downgrades. Across 10 firms with a ORCL price target in the last 12 months, the median target is $219. Oppenheimer's $235 is 7% above that.
- Current rating
- Outperform
- Price target
- $235
- Median target, all firms
- $219
- Actions on ORCL
- 4
Oppenheimer price target on ORCL
Every Oppenheimer rating on ORCL
- May 12, 2026
- Mar 11, 2026
- Feb 25, 2026
- Apr 18, 2024
How other firms rate ORCL
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Stephens | Overweight | $213 | Nov 2, 2026 |
| BMO Capital Markets | Outperform | $195 | Sep 11, 2026 |
| CLSA | Hold | $145 | Jul 20, 2026 |
| Oppenheimer | Outperform | $235 | May 12, 2026 |
| Arete Research | Buy | $255 | May 7, 2026 |
| Wedbush | Outperform | $225 | Apr 24, 2026 |
| Cleveland Research | Neutral | Apr 10, 2026 | |
| BofA Securities | Buy | $200 | Mar 24, 2026 |
| Melius | Hold | Feb 9, 2026 | |
| DA Davidson | Buy | $180 | Feb 9, 2026 |
| Goldman Sachs | Buy | $240 | Jan 12, 2026 |
| Wells Fargo | Overweight | $280 | Dec 3, 2025 |
| Erste Group | Hold | Nov 10, 2025 |
Questions about Oppenheimer and ORCL
- What is Oppenheimer's price target for ORCL?
- Oppenheimer's latest stated price target for Oracle Corporation (ORCL) is $235, from its action on May 12, 2026.
- What is Oppenheimer's rating on ORCL?
- Oppenheimer rates ORCL Outperform, a bullish rating, as of May 12, 2026.
- When did Oppenheimer last change its view on ORCL?
- On May 12, 2026, Oppenheimer raises its price target to $235 from $210, keeps Outperform.
- How does Oppenheimer's ORCL target compare with other analysts?
- Across 10 firms with a ORCL price target in the last 12 months, the median target is $219. Oppenheimer's $235 is 7% above that.
More ORCL rating histories
- BMO Capital Markets19
- BofA Securities3
- Goldman Sachs3
- Citigroup3
- Piper Sandler6
- Monness, Crespi, Hardt6
- KeyBanc Capital Markets6
- DZ Bank3
- Barclays3
- Societe Generale3
- Deutsche Bank3
All Oppenheimer ratingsORCL news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.